Sectors
Capabilities
Specialisms
Women’s health is finally getting the attention it deserves, but that has not yet translated into shorter times for diagnosis, transformed clinical trial strategies or more innovative treatment approaches being made available to the women who need it.
That was the tension running through conversations at the recent Women’s Health Horizons London Autumn Summit. The questions were about how to turn growing ambition into action and deliver care that works in real life.
For healthcare marketing and communications leaders, that gap raises some useful questions about where to focus next. Where can they channel their ambition and attention. There is room to rethink awareness and education, especially as AI changes how people find health information.
Four challenges stood out.
This might feel like an obvious statement. Menstrual health, fertility and menopause remain essential parts of the conversation. But a women’s health strategy that stops there misses much of women’s experience of healthcare.
Cardiovascular disease, osteoporosis, chronic pain and GI track diseases all affect women in larger numbers, or very differently from men. Women now live longer after their reproductive years, yet women’s health continues to be mainly categorised through a gynaecology lens.
That wider view can make campaigns more relevant to women’s lives and to the people making decisions about their care.
Lived experience, real-world data and digital monitoring may help show what a condition or treatment means day to day. Those insights can strengthen both public education and the case for adopting new approaches to care.
Access to care might begin at home, in a pharmacy or GP surgery, but increasingly today, it starts in online communities where someone first recognises their symptoms in another woman’s story.
With that in mind, the discussion challenged the idea that we need more content.
There is certainly room for fresher education built around the questions women are asking. That could mean working with trusted creators and communities, asking experts to review information already circulating, and making the next step towards appropriate care clear. And it also means checking whether reliable sources surface in AI answers.
Several discussions also brought up to the value of listening in those spaces. Women are already using social media to compare experiences, make sense of symptoms and find routes into care.
Listening is part of that work. It helps reveal the questions women ask before they enter the health system, the barriers they encounter and the language that makes advice useful to them when seeking care.
The discussion on moving innovation from lab to market brought out an important distinction. Especially as innovation in women’s health has been a long time coming.
A diagnostic or treatment may be approved, but health systems still need evidence that it works in a care pathway and merits investment against competing priorities.
In women’s health, that case needs to reflect more than a clinical endpoint. Pain, mental health, time to diagnosis and the ability to work all matter to patients. Digital tools and wearables could help capture some of that experience alongside clinical and real-world evidence.
For launch teams, the lesson is to plan for adoption early. The patient story, evidence plan and communications approach need to answer the questions clinicians, commissioners and women themselves will ask after approval.
Communications can make the case clearer across patients, clinicians, commissioners and policymakers. It cannot fill a gap in the evidence which remains essential, but it can help ensure the evidence reflects the problem the innovation is meant to solve.
Awareness of women’s health gaps has grown. The harder task is changing how research, development and launch decisions are made.
The pharma discussion pressed for closer attention to gender differences in clinical research: recruitment, outcomes, side effects, dose and treatment response. It also challenged organisations to look beyond a collection of individual women’s health initiatives towards a consistent approach across research teams and therapy areas.
Better data can reveal underserved groups, improve patient information and support a more useful conversation about the value of care.
Women’s health has no shortage of advocates or ideas. The opportunity now is to connect those voices to research, investment and delivery.
That means listening to women, including those who are not yet accessing care; finding practical ways to build evidence that supports faster diagnosis; and rethinking services so that care is more local, accessible and holistic.
For healthcare leaders, the measure of progress is whether more women can find the right care at the right time and benefit from it. By translating these priorities into everyday practice, we can turn the growing public conversation around women’s health into meaningful action.
See all